A carregar...

Patient-Reported Symptoms and Discontinuation of Adjuvant Aromatase Inhibitor Therapy

BACKGROUND: Aromatase inhibitor (AI) therapy results in substantial survival benefits in hormone receptor-positive breast cancer. Poor adherence and discontinuation rates of AI therapy are high, primarily due to treatment-related toxicities such as musculoskeletal pain. While pain-related symptoms m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kidwell, Kelley M., Harte, Steven E., Hayes, Daniel F., Storniolo, Anna Maria, Carpenter, Janet, Flockhart, David A., Stearns, Vered, Clauw, Daniel J., Williams, David A., Henry, N. Lynn
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126845/
https://ncbi.nlm.nih.gov/pubmed/24802413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28756
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!